AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of AGEPHA Pharma US.

    Client Virtual Booth

    AGEPHA PHARMA US

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    AGEPHA Pharma US
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Parsippany, NJ
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://us.agephapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agepha-pharma-us/
    Twitter
    Twitter
    https://twitter.com/AGEPHAPharmaUS

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Agepha Pharma and Caristo Diagnostics Team up to Fight Coronary Inflammation

    Details:

    The collaboration will support clinical research involving the CaRi-Heart technology for coronary inflammation diagnostics and FDA-approved LODOCO (colchicine) tablets for therapeutic intervention.


    Lead Product(s): Colchicine

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: Lodoco

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Caristo Diagnostics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration January 16, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

    Details:

    LODOCO (colchicine, 0.5 mg tablet) through inhibition of beta-tubulin polymerization which is indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization.


    Lead Product(s): Colchicine

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: Lodoco

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 20, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    transo-pharm-handels-gmbh-m-2024-05-20

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search